• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性/早期HIV-1感染后较高的病毒传播率。

High rates of forward transmission events after acute/early HIV-1 infection.

作者信息

Brenner Bluma G, Roger Michel, Routy Jean-Pierre, Moisi Daniela, Ntemgwa Michel, Matte Claudine, Baril Jean-Guy, Thomas Rejéan, Rouleau Danielle, Bruneau Julie, Leblanc Roger, Legault Mario, Tremblay Cecile, Charest Hugues, Wainberg Mark A

机构信息

McGill AIDS Centre-Jewish General Hospital, Montreal, Canada.

出版信息

J Infect Dis. 2007 Apr 1;195(7):951-9. doi: 10.1086/512088. Epub 2007 Feb 16.

DOI:10.1086/512088
PMID:17330784
Abstract

BACKGROUND

A population-based phylogenetic approach was used to characterize human immunodeficiency virus (HIV)-transmission dynamics in Quebec.

METHODS

HIV-1 pol sequences included primary HIV infections (PHIs; <6 months after seroconversion) from the Quebec PHI cohort (1998-2005; n=215) and the provincial genotyping program (2001-2005; n=481). Phylogenetic analysis determined sequence interrelationships among unique PHIs (n=593) and infections from untreated (n=135) and treated (n=660) chronically infected (CI) potential transmitter populations (2001-2005). Clinical features, risk factors, and drug resistance for clustered and nonclustered transmission events were ascertained.

RESULTS

Viruses from 49.4% (293/593) of PHIs cosegregated into 75 transmission chains with 2-17 transmissions/cluster. Half of the clusters included 2.7+/-0.8 (mean+/-SD) transmissions, whereas the remainder had 8.8+/-3.5 transmissions. Maximum periods for onward transmission in clusters were 15.2+/-9.5 months. Coclustering of untreated and treated CIs with PHIs were infrequent (6.2% and 4.8%, respectively). The ages, viremia, and risk factors were similar for clustered and nonclustered transmission events. Low prevalence of drug resistance in PHI supported amplified transmissions at early stages.

CONCLUSIONS

Early infection accounts for approximately half of onward transmissions in this urban North American study. Therapy at early stages of disease may prevent onward HIV transmission.

摘要

背景

采用基于人群的系统发育方法来描述魁北克省人类免疫缺陷病毒(HIV)的传播动态。

方法

HIV-1 pol序列包括来自魁北克原发性HIV感染队列(1998 - 2005年;n = 215)和省级基因分型项目(2001 - 2005年;n = 481)的原发性HIV感染(PHIs;血清转换后<6个月)。系统发育分析确定了独特的PHIs(n = 593)以及来自未治疗(n = 135)和治疗(n = 660)的慢性感染(CI)潜在传播人群(2001 - 2005年)的感染之间的序列相互关系。确定了聚集性和非聚集性传播事件的临床特征、危险因素和耐药性。

结果

49.4%(293/593)的PHIs病毒共分为75个传播链,每个聚集簇有2 - 17次传播。一半的聚集簇包含2.7±0.8(均值±标准差)次传播,而其余的有8.8±3.5次传播。聚集簇中后续传播的最长时间为15.2±9.5个月。未治疗和治疗的慢性感染者与PHIs的共聚集情况不常见(分别为6.2%和4.8%)。聚集性和非聚集性传播事件的年龄、病毒血症和危险因素相似。PHI中耐药性的低流行率支持了早期阶段传播的增加。

结论

在这项北美城市研究中,早期感染约占后续传播病例的一半。疾病早期进行治疗可能会预防HIV的后续传播。

相似文献

1
High rates of forward transmission events after acute/early HIV-1 infection.急性/早期HIV-1感染后较高的病毒传播率。
J Infect Dis. 2007 Apr 1;195(7):951-9. doi: 10.1086/512088. Epub 2007 Feb 16.
2
Infrequent transmission of HIV-1 drug-resistant variants.HIV-1耐药变异株的不频繁传播。
Antivir Ther. 2004 Jun;9(3):375-84.
3
Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naïve seroconverters in Singapore.新加坡急性和近期初治未经药物治疗的血清转化者中 HIV-1 的原发性耐药和传播分析。
HIV Med. 2009 Jul;10(6):370-7. doi: 10.1111/j.1468-1293.2009.00698.x. Epub 2009 Mar 11.
4
Transmission networks of drug resistance acquired in primary/early stage HIV infection.在原发性/早期HIV感染中获得的耐药性传播网络。
AIDS. 2008 Nov 30;22(18):2509-15. doi: 10.1097/QAD.0b013e3283121c90.
5
Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008.2000 年至 2008 年间在意大利诊断的 HIV-1B 感染患者的流行病学网络分析。
Infect Genet Evol. 2011 Apr;11(3):624-32. doi: 10.1016/j.meegid.2011.01.019. Epub 2011 Feb 1.
6
Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.多哥HIV-1毒株的基因特征揭示了初治抗逆转录病毒治疗患者中存在高度的基因复杂性和基因型耐药突变。
Infect Genet Evol. 2009 Jul;9(4):646-52. doi: 10.1016/j.meegid.2009.04.002. Epub 2009 Apr 15.
7
Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations.对来自巴拿马的HIV-1 pol序列的分析:B亚型内系统发育簇的鉴定及抗逆转录病毒药物耐药性突变的检测。
Infect Genet Evol. 2009 Sep;9(5):933-40. doi: 10.1016/j.meegid.2009.06.013. Epub 2009 Jun 24.
8
Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.西班牙马德里未接受治疗和已接受治疗的 HIV-1 感染儿科人群中的耐药流行率和 HIV-1 变异特征。
J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2.
9
Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.意大利早期HIV感染诊断多中心护理网络的实施:1999 - 2001年报告
J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):73-8.
10
Molecular and phylogenetic characterization of HIV variants in Italian primary HIV infections (PHI): identification of non-B subtype variants.意大利原发性HIV感染(PHI)中HIV变异株的分子及系统发育特征:非B亚型变异株的鉴定
J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):44-8.

引用本文的文献

1
Acute HIV-1 Infection: Paradigm and Singularity.急性人类免疫缺陷病毒1型感染:范例与独特性
Viruses. 2025 Mar 3;17(3):366. doi: 10.3390/v17030366.
2
Analysis of HIV-1 recent infections and hotspot areas in a bordering area in Yunnan Province, China.中国云南省边境地区HIV-1近期感染情况及热点区域分析
BMC Public Health. 2025 Mar 24;25(1):1122. doi: 10.1186/s12889-025-21877-3.
3
Dynamics of clustering rates in the Rhode Island HIV-1 epidemic.罗得岛州HIV-1疫情中的聚集率动态变化
AIDS. 2025 Feb 1;39(2):105-114. doi: 10.1097/QAD.0000000000004062. Epub 2024 Nov 8.
4
Clinical-epidemiological profile and factors associated with viral non-suppression in patients living with HIV/AIDS assisted at the Integrated Treatment Center at the Maputo Military Hospital (CITRA/MMH), 2019 to 2020.2019 年至 2020 年,在马普托军事医院综合治疗中心(CITRA/MMH)接受治疗的艾滋病毒/艾滋病患者的临床流行病学特征及与病毒抑制失败相关的因素。
BMC Infect Dis. 2024 Jul 20;24(1):713. doi: 10.1186/s12879-024-09616-2.
5
Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological study.澳大利亚维多利亚州HIV-1传播特征:一项分子流行病学研究
Lancet Reg Health West Pac. 2024 Jun 7;47:101103. doi: 10.1016/j.lanwpc.2024.101103. eCollection 2024 Jun.
6
Identification of a circulating long non-coding RNA signature panel in plasma as a novel biomarker for the detection of acute/early-stage HIV-1 infection.鉴定血浆中循环长链非编码RNA特征谱作为检测急性/早期HIV-1感染的新型生物标志物。
Biomark Res. 2024 Jun 12;12(1):61. doi: 10.1186/s40364-024-00597-7.
7
The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject Matter.人类免疫缺陷病毒治疗背景下的抗逆转录病毒药物耐药现象:动态且不断演变的主题。
Biomedicines. 2024 Apr 20;12(4):915. doi: 10.3390/biomedicines12040915.
8
Molecular epidemiology to aid virtual elimination of HIV transmission in Australia.分子流行病学助力澳大利亚实现艾滋病病毒传播的虚拟消除。
Virus Res. 2024 Mar;341:199310. doi: 10.1016/j.virusres.2024.199310. Epub 2024 Jan 11.
9
The Role of Late Presenters in HIV-1 Transmission Clusters in Europe.在欧洲的 HIV-1 传播集群中晚期出现者的作用。
Viruses. 2023 Dec 13;15(12):2418. doi: 10.3390/v15122418.
10
HIV testing: the cornerstone of HIV prevention efforts in the USA.艾滋病毒检测:美国预防艾滋病毒工作的基石。
Future Virol. 2011 Nov;6(11). doi: 10.2217/fvl.11.114.